The Open AIDS Journal

ISSN: ― Volume ,

Is Back-Projection Methodology Still Relevant for Estimating HIV Incidence from National Surveillance Data?

Kylie-Ann Mallitt, David P Wilson* , Ann McDonald, Handan Wand
The Kirby Institute, University of New South Wales, Sydney, Australia


Accurate estimates of HIV incidence are crucial to understand the extent of transmission of the infection, evaluate intervention strategies and effectively plan new public health control measures. HIV/AIDS surveillance systems in numerous industrialised countries record the number of known new HIV and/or AIDS diagnoses, which are often used as a surrogate marker for HIV incidence. HIV/AIDS diagnosis data have been used to reconstruct historical HIV incidence trends using modified back-projection methods. Estimates of HIV incidence are most robust when reliable data on the number of incident infections, a subset of all diagnoses, is widely available, and surveillance systems should prioritise the collection of these data. Back-projection alone provides reliable estimates of HIV incidence in the past, but is not useful when estimating current or future HIV incidence. However, back-projection methodology should be used in conjunction with other corroborative methods to estimate current HIV incidence, and methods to combine the various techniques should be investigated.

Keywords: AIDS, back-calculation, undiagnosed HIV, HIV testing..

Article Information

Identifiers and Pagination:

Year: 2012
Volume: 6
Issue: Suppl 1
First Page: 108
Last Page: 111
Publisher Id: TOAIDJ-6-108
DOI: 10.2174/1874613601206010108

Article History:

Received Date: 15/4/2011
Revision Received Date: 28/10/2011
Acceptance Date: 20/2/2012
Electronic publication date: 7/9/2012
Collection year: 2012

© Mallitt et al.; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at the Kirby Institute, University of New South Wales, Sydney, Australia; Tel: +61 2 9385 0959; Fax: +61 2 9385 0920; E-mail:

Track Your Manuscript:


"Publishing with Bentham Open was a great experience. The timeliness and communication were outstanding. I am hopeful that I will have the opportunity to publish with Bentham Open again in the future."

Dr. Daniel B. Chastain
Pharm.D., AAHIVP, Clinical Pharmacy Specialist, Infectious Diseases, Phoebe Health, USA

SCImago Journal Ranking

SCImago Journal & Country Rank

Browse Contents

Webmaster Contact:
Copyright © 2021 Bentham Open